Evidence map›Paper›PMID 23899389›Full record

ArticleBiochemistry2013

Novel interactions of the TRTK12 peptide with S100 protein family members: specificity and thermodynamic characterization.

Lucas N Wafer, Franco O Tzul, Pranav P Pandharipande, George I Makhatadze

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. S100 proteins as therapeutic targets.Biophysical reviews · 2018
    Review
  5. Evidence for the principle of minimal frustration in the evolution of protein folding landscapes.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lucas N WaferDepartment of Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York 12180, United States.
Franco O Tzul
Pranav P Pandharipande
George I Makhatadze
Rensselaer Polytechnic Institute · US

Funding

RULES FOR HELIX TERMINATION, THE C CAPPING BOXR01GM054537 · NIGMS · TEXAS TECH UNIVERSITY · PI MAKHATADZE, GEORGE I · 1998 to 2010
$2.2M
NIGMS NIH HHS R01 GM054537NIGMS NIH HHS R01-GM054537
6 · The paper itself

Abstract

The S100 protein family consists of small, dimeric proteins that exert their biological functions in response to changing calcium concentrations. S100B is the best-studied member and has been shown to interact with more than 20 binding partners in a calcium-dependent manner. The TRTK12 peptide, derived from the consensus binding sequence for S100B, has previously been found to interact with S100A1 and has been proposed to be a general binding partner of the S100 family. To test this hypothesis and gain a better understanding of the specificity of binding for the S100 proteins, 16 members of the human S100 family were screened against this peptide and its alanine variants. Novel interactions were found with only two family members, S100P and S100A2, indicating that TRTK12 selectively interacts with a small subset of the S100 proteins. Substantial promiscuity was observed in the binding site of S100B thereby accommodating variations in the peptide sequence, while S100A1, S100A2, and S100P exhibited larger differences in the binding constants for the TRTK12 alanine variants. This suggests that single-point substitutions can be used to selectively modulate the affinity of TRTK12 peptides for individual S100 proteins. This study has important implications for the rational drug design of inhibitors for the S100 proteins, which are involved in a variety of cancers and neurodegenerative diseases.

Indexed as

Amino Acid SubstitutionCalcium-Binding ProteinsCalorimetryCapZ Actin Capping ProteinChemotactic FactorsHumansNeoplasm ProteinsNerve Growth FactorsOligopeptidesPeptide FragmentsS100 Calcium Binding Protein beta SubunitS100 ProteinsThermodynamicsCalcium-Binding ProteinsCapZ Actin Capping ProteinChemotactic FactorsNeoplasm ProteinsNerve Growth FactorsOligopeptidesPeptide FragmentsS100A1 proteinS100A2 protein, humanS100B protein, humanS100 Calcium Binding Protein beta SubunitS100P protein, humanS100 ProteinsTRTK-12 peptide

Identifiers

PMID23899389
PMCPMC3839042
OpenAlexW1963878258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.